first floor, 85 great portland street, london, W1W 7LT
Website
-
london urological surgeons limitedEstimated Valuation
£2.1m
Pomanda estimates the enterprise value of LONDON UROLOGICAL SURGEONS LIMITED at £2.1m based on a Turnover of £5.3m and 0.41x industry multiple (adjusted for size and gross margin).
london urological surgeons limitedEstimated Valuation
£1.8m
Pomanda estimates the enterprise value of LONDON UROLOGICAL SURGEONS LIMITED at £1.8m based on an EBITDA of £604.4k and a 2.9x industry multiple (adjusted for size and gross margin).
london urological surgeons limitedEstimated Valuation
£5.5m
Pomanda estimates the enterprise value of LONDON UROLOGICAL SURGEONS LIMITED at £5.5m based on Net Assets of £2.8m and 2.01x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
London Urological Surgeons LimitedOverview
London Urological Surgeons Limited is a live company located in london, W1W 7LT with a Companies House number of 07220103. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in April 2010, it's largest shareholder is
leyla entezari
with a 50% stake. London Urological Surgeons Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£5.3m with
high
growth in recent years.
Pomanda's financial health check has awarded London Urological Surgeons Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
4 Strong
1 Regular
5 Weak
Size
annual sales of £5.3m, make it larger than the average company (£488.2k)
£5.3m - London Urological Surgeons Limited
£488.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (7.6%)
21% - London Urological Surgeons Limited
7.6% - Industry AVG
Production
with a gross margin of 30.1%, this company has a higher cost of product (52.8%)
30.1% - London Urological Surgeons Limited
52.8% - Industry AVG
Profitability
an operating margin of 11.5% make it less profitable than the average company (14.7%)
11.5% - London Urological Surgeons Limited
14.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (11)
2 - London Urological Surgeons Limited
11 - Industry AVG
Pay Structure
on an average salary of £30.5k, the company has an equivalent pay structure (£30.5k)
£30.5k - London Urological Surgeons Limited
£30.5k - Industry AVG
Efficiency
resulting in sales per employee of £2.6m, this is more efficient (£72.7k)
£2.6m - London Urological Surgeons Limited
£72.7k - Industry AVG
Debtor Days
it gets paid by customers after 173 days, this is later than average (37 days)
173 days - London Urological Surgeons Limited
37 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (34 days)
17 days - London Urological Surgeons Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - London Urological Surgeons Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - London Urological Surgeons Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.9%, this is a lower level of debt than the average (29.4%)
5.9% - London Urological Surgeons Limited
29.4% - Industry AVG
LONDON UROLOGICAL SURGEONS LIMITED financials
EXPORT
London Urological Surgeons Limited's latest turnover from March 2024 is estimated at £5.3 million and the company has net assets of £2.8 million. According to their latest financial statements, London Urological Surgeons Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Turnover
5,253,682
4,532,160
3,517,865
2,943,243
2,601,285
1,734,555
2,703,983
2,963,942
1,083,868
954,905
341,242
343,674
386,099
163,645
Other Income Or Grants
Cost Of Sales
3,672,955
3,139,786
2,272,116
1,969,877
1,627,335
1,081,661
1,566,702
1,632,251
636,672
506,553
182,610
159,550
195,412
86,952
Gross Profit
1,580,727
1,392,374
1,245,749
973,366
973,950
652,894
1,137,281
1,331,691
447,197
448,352
158,632
184,123
190,687
76,693
Admin Expenses
976,302
868,759
744,340
655,443
681,217
469,340
1,027,672
1,185,400
371,468
330,163
-65,643
41,395
10,823
5,593
Operating Profit
604,425
523,615
501,409
317,923
292,733
183,554
109,609
146,291
75,729
118,189
224,275
142,728
179,864
71,100
Interest Payable
Interest Receivable
617
2,233
2,058
1,701
943
449
150
Pre-Tax Profit
604,425
523,615
501,409
317,923
292,733
183,554
109,609
146,908
77,963
120,247
225,977
143,671
180,314
71,250
Tax
-151,106
-99,487
-95,268
-60,405
-55,619
-34,875
-20,826
-29,381
-15,592
-25,252
-51,975
-34,481
-46,882
-19,950
Profit After Tax
453,319
424,128
406,141
257,518
237,114
148,679
88,783
117,526
62,370
94,995
174,002
109,190
133,432
51,300
Dividends Paid
Retained Profit
453,319
424,128
406,141
257,518
237,114
148,679
88,783
117,526
62,370
94,995
174,002
109,190
133,432
51,300
Employee Costs
60,923
58,902
53,946
52,400
51,532
52,933
515,730
614,709
261,690
239,104
89,555
115,425
159,821
72,702
Number Of Employees
2
2
2
2
2
2
21
23
9
8
3
4
6
3
EBITDA*
604,425
523,615
501,409
317,923
292,733
183,554
109,609
146,291
80,412
138,456
244,542
162,995
200,492
87,158
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Tangible Assets
431,098
387,051
96,853
57,899
58,274
47,680
88,161
67,991
1,223
1,080
2,162
3,242
4,322
263
Intangible Assets
1
3,198
22,384
41,571
60,758
79,945
Investments & Other
66,645
66,645
66,645
26,370
26,370
Debtors (Due After 1 year)
Total Fixed Assets
431,098
387,051
96,853
57,899
58,274
47,680
88,161
67,991
67,869
70,923
91,191
71,183
91,450
80,208
Stock & work in progress
Trade Debtors
2,500,454
2,122,142
1,981,861
1,610,694
1,261,147
1,001,158
814,694
775,258
206,051
173,589
56,634
57,500
58,668
17,598
Group Debtors
Misc Debtors
Cash
493,355
399,994
423,283
257,312
119,734
59,890
misc current assets
total current assets
2,500,454
2,122,142
1,981,861
1,610,694
1,261,147
1,001,158
814,694
775,258
699,406
573,583
479,917
314,812
178,402
77,488
total assets
2,931,552
2,509,193
2,078,714
1,668,593
1,319,421
1,048,838
902,855
843,249
767,275
644,506
571,108
385,995
269,852
157,696
Bank overdraft
Bank loan
Trade Creditors
173,055
204,015
197,664
193,684
102,030
68,561
71,257
100,434
141,586
81,187
102,784
91,673
84,720
105,996
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
173,055
204,015
197,664
193,684
102,030
68,561
71,257
100,434
141,586
81,187
102,784
91,673
84,720
105,996
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
173,055
204,015
197,664
193,684
102,030
68,561
71,257
100,434
141,586
81,187
102,784
91,673
84,720
105,996
net assets
2,758,497
2,305,178
1,881,050
1,474,909
1,217,391
980,277
831,598
742,815
625,689
563,319
468,324
294,322
185,132
51,700
total shareholders funds
2,758,497
2,305,178
1,881,050
1,474,909
1,217,391
980,277
831,598
742,815
625,689
563,319
468,324
294,322
185,132
51,700
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Operating Activities
Operating Profit
604,425
523,615
501,409
317,923
292,733
183,554
109,609
146,291
75,729
118,189
224,275
142,728
179,864
71,100
Depreciation
1,486
1,080
1,080
1,080
1,441
69
Amortisation
3,197
19,187
19,187
19,187
19,187
15,989
Tax
-151,106
-99,487
-95,268
-60,405
-55,619
-34,875
-20,826
-29,381
-15,592
-25,252
-51,975
-34,481
-46,882
-19,950
Stock
Debtors
378,312
140,281
371,167
349,547
259,989
186,464
39,436
569,207
32,462
116,955
-866
-1,168
41,070
17,598
Creditors
-30,960
6,351
3,980
91,654
33,469
-2,696
-29,177
-41,152
60,399
-21,597
11,111
6,953
-21,276
105,996
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
44,047
290,198
38,954
-375
10,594
-40,481
20,170
-493,449
92,757
-25,348
204,544
136,635
91,264
155,606
Investing Activities
capital expenditure
-44,047
-290,198
-38,954
375
-10,594
40,481
-20,170
-66,767
-1,629
1
-5,500
-96,266
Change in Investments
-66,645
40,275
26,370
cash flow from investments
-44,047
-290,198
-38,954
375
-10,594
40,481
-20,170
-122
-1,629
1
-40,275
-31,870
-96,266
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-400
400
interest
617
2,233
2,058
1,701
943
449
150
cash flow from financing
217
2,233
2,058
1,701
943
449
550
cash and cash equivalents
cash
-493,355
93,361
-23,289
165,971
137,578
59,844
59,890
overdraft
change in cash
-493,355
93,361
-23,289
165,971
137,578
59,844
59,890
london urological surgeons limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for london urological surgeons limited. Get real-time insights into london urological surgeons limited's credit score, group structure and payment trends.
London Urological Surgeons Limited Competitor Analysis
Perform a competitor analysis for london urological surgeons limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in W1W area or any other competitors across 12 key performance metrics.
london urological surgeons limited Ownership
LONDON UROLOGICAL SURGEONS LIMITED group structure
London Urological Surgeons Limited has no subsidiary companies.
Ultimate parent company
LONDON UROLOGICAL SURGEONS LIMITED
07220103
LONDON UROLOGICAL SURGEONS LIMITED Shareholders
The largest shareholders in London Urological Surgeons Limited include Leyla Entezari and Bijan Khoubehi.
leyla entezari
50%
bijan khoubehi
50%
london urological surgeons limited directors
London Urological Surgeons Limited currently has 2 directors.
The longest serving directors include
Mr Bijan Khoubehi (Apr 2010) and
Mrs Leyla Entezari (Jan 2020).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024
net assets
2.8m
+0.2%
total assets
2.9m
+0.17%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
london urological surgeons limited company details
company number
07220103
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
April 2010
age
15
incorporated
UK
ultimate parent company
None
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
first floor, 85 great portland street, london, W1W 7LT
Bank
-
Legal Advisor
-
london urological surgeons limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to london urological surgeons limited.
london urological surgeons limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LONDON UROLOGICAL SURGEONS LIMITED. This can take several minutes, an email will notify you when this has completed.
london urological surgeons limitedCompanies House Filings - See Documents
